CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter

Nature Immunology

Volumn 2, Issue 7, 2001, Pages 652-657

  Beresford, G W ^a   Boss, J M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE H3; HISTONE H4; HLA DR ANTIGEN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN;

ACETYLATION; ARTICLE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MUTANT; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; TIME;

ACETYLATION; ACETYLTRANSFERASES; CELL LINE; GENES, MHC CLASS II; HELA CELLS; HISTONE ACETYLTRANSFERASES; HISTONES; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LYSINE; NUCLEAR PROTEINS; NUCLEOSOMES; PROMOTER REGIONS (GENETICS); SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATORS;

EID: 0034913587     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/89810     Document Type: Article

References (60)

1. A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes
2. The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression
3. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
4. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Spl and NF-Y
5. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region
6. Genomic organization of HLA-DMA and HLA-DMB
7. Induction of MHC class I expression by the MHC class II transactivator CIITA
8. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: The ISRE-mediate route and a novel pathway involving CIITA
9. Combined immunodeficiency with defective expression in MHC class II genes
10. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis
11. Genetic complexity of regulatory mutants defective for HLA class II expression
12. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, a MHC class II immunodeficiency
13. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
14. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
15. RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency
16. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA
17. Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells
18. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA
19. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
20. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
21. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein
22. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32
23. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes
24. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator
25. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
26. Formaldehyde cross-linking and immunoprecipitation demonstrate developmental changes in HI associated with transcriptionally active genes
27. Mapping DNA interaction sites of chromosomal proteins using immunoprecipitation and polymerase chain reaction
28. CREB regulates MHC class II expression in a CIITA-dependent manner
29. Associations and interactions among the bare lymphocyte syndrome factors
30. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
31. Real time quantitative PCR
32. Continuous fluorescence monitoring of rapid cycle DNA amplification
33. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5
34. In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome
35. Transcriptional activation and chromatin remodeling of the HIV-I promoter in response to histone acetylation
36. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes
37. The SAGA unfolds: Convergence of transcription regulators in chromatin-modifying complexes
38. Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo
39. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
40. Acetylation of histones and transcription-related factors
41. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts
42. Mutation analysis of the MHC class II transactivator (CIITA) indicates a functional requirement for conserved LCD motifs and for interactions with the conserved W-box promoter element
43. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250
44. Overlapping but ditinct patterns of histione acetylation by the human coactivators p300 and PCAF within nucleosome substrates
45. The language of covalent histone modifications
46. The Drosophila MSL complex acetylates histone H4 at Lysine 16, a chromatin modication linked to dosage compensation
47. Special HATs for special occasions: Linking histone acetylation to chromatin assembly and gene activation
48. In vivo footprint analysis of the HLA-DRA gene promoter: Cell-specific interaction at the octamer site and up-regulation of X box binding by interferon γ
49. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo
50. A p300/CBP-associated factor that competes with the adenoviral oncoprotein EIA
51. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes
52. Phosphorylated CREB binds specifically to the nuclear protein CBP
53. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF
54. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strains Raji)
55. Human B cell variants immunoselected against a single la antigen subset have lost expression of several la antigen subsets
56. Two complementation groups account for most cases of inherited MHC class II deficiency
57. HLA gene amplification and hybridization analysis of polymorphism HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome
58. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells
59. Class II MHC transcriptional mutants are defective in higher order complex formation